Our team

Just as Mayo Clinic uses a team of specialists to provide the best care for our patients, the Department of Business Development has employed its own robust group of experts to ensure the successful evaluation and development of ideas, inventions and know-how, along with the analysis of strategic business transactions to include partnerships, strategic collaborations, equity investments, mergers and acquisitions.

Department of Business Development Executive Leadership

Jim Rogers III — Chief Business Development Officer
James A. Rogers III

Medical Director, Business Development
Peter A. Noseworthy, MD, MBA

Chair, Mayo Clinic Ventures
Andrew J. Danielsen

Chair, Corporate Development - Clinical Practice & High Value Opportunities
Manu Nair

Chair, Corporate Development - International & Mayo Clinic Labs
Sami Yusuf

Chair, Corporate Development
Brian Zargham

Assistant Medical Director, Business Development
Barham K. Abu Dayyeh, MD, MPH

Associate Medical Director - FL, Business Development
Olayemi Sokumbi, MD

Associate Medical Director - AZ, Business Development
Steven J. Lester, MD

Chief Business Development Officer

James A. Rogers III

James (Jim) A. Rogers III serves as Chief Business Development Officer for Mayo Clinic’s Department of Business Development and Interim Senior Administrator for Strategy. Jim oversees Mayo Clinic’s Department of Business Development – the institution’s front door for licensing Mayo Clinic intellectual property and partnering with industry to fill capability gaps through an array of avenues to include invention patenting, technology licensing and commercialization, start-up formation, strategic collaborations, venture investing and acquisitions. Jim facilitates the group’s charge of proactively enabling Mayo Clinic’s strategic priorities and generating revenue to reinvest back into the three-shield mission of practice, education and research.

Jim is secretary of the Business Development Committee for the Mayo Clinic Board of Trustees and is on the board of Mayo Clinic Collaborative Services, Inc., Mayo Clinic’s billion dollar diagnostic laboratory company. He also serves on the Mayo Clinic Administrative Team, Mayo Clinic Administrative Team Executive Committee, Administrative Operations Coordinating Group, Mayo Clinic Shared Services, and the investment committee of Mayo Clinic’s $100M Venture and Growth Fund. He has also served on several external boards including Medical Alley Association, Rochester Area Economic Development, Inc., Lourdes Foundation and Merchants Bank.

Before joining Mayo Clinic, Jim worked at Dorsey & Whitney, LLP and 3M Company. He is a graduate of the University of Iowa and University of Iowa College of Law where he earned his B.S. in biology and his J.D. with high distinction.

Medical Director, Business Development

Peter A. Noseworthy, MD, MBA

Peter Noseworthy, MD, MBA, serves as Medical Director for the Department of Business Development and is a Professor of Medicine and Cardiac Electrophysiologist.

In his role as Medical Director, Dr. Noseworthy oversees proactive business partnerships and strategic collaborations, mergers and acquisitions, equity investing and the commercialization of Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research and education at Mayo Clinic.

Dr. Noseworthy joined the Mayo Clinic faculty in 2013 after completing his internal medicine, cardiology, chief residency and electrophysiology training at Massachusetts General Hospital in Boston, MA. He completed his Master of Business Administration from MIT in 2023. He has closely partnered with Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to maintain a federally funded research program that leverages cutting-edge research methods as well as emerging data and technologies. This work has led to a series of high-impact publications that address questions important to patients, clinicians and health systems.

In addition to his research and clinical activities, Dr. Noseworthy serves as Director of the Mayo Clinic Heart Rhythm and Physiologic Monitoring Laboratory where he oversees the development of novel ECG software-based analysis tools, many of which have resulted in the filing of intellectual property disclosures and several patents.

Chair, Mayo Clinic Ventures

Andrew J. Danielsen

Andrew (Andy) Danielsen serves as Chair of Mayo Clinic Ventures in the Department of Business Development where he oversees the group’s licensing, technology development, venture investment and business development functions.

Andy serves on several committees throughout Mayo Clinic, including the Executive Subcommittee of the Medical-Industry Relations Committee. He is also a member of multiple groups responsible for funding innovative new technologies or startup companies to include the Mayo Clinic Venture Fund Investment Committee, the Discovery Translation Program, and the Department of Business Development Investment Committee.

Prior to joining Mayo Clinic Ventures in 2002, Andy conducted research at Mayo Clinic to identify therapeutic targets in breast and ovarian cancer.

Andy received his BS in biochemistry and molecular biology from the University of Wisconsin-Eau Claire and his MS in molecular biology from Mayo Clinic Graduate School of Biomedical Sciences.

Chair, Corporate Development - Clinical Practice & High Value Opportunities

Manu Nair

Manu Nair serves as Chair of Corporate Development for Clinical Practice and High Value Opportunities where he leads business development efforts focused on opportunities that are of highest strategic importance to Mayo Clinic.

Manu previously served as vice president of Technology Ventures for the Oklahoma Medical Research Foundation (OMRF) in Oklahoma City prior to joining Mayo Clinic in 2020. He received his MBA from Lamar University in Texas and an advanced degree in law from the University of New Hampshire School of Law focusing on intellectual property, commerce and technology laws. He serves on the boards of several U.S. companies.

Chair, Corporate Development - International & Mayo Clinic Labs

Sami Yusuf

Sami Yusuf serves as Chair of Corporate Development for International where he is responsible for driving partnerships, strategic collaborations and strategic alliances by coordinating, negotiating, and executing strategic transactions in support of Mayo Clinic and its International business.

Sami has robust experience across leadership positions in research and development, alliance management, portfolio strategy, corporate strategy, and corporate development from small cap privately held companies to fortune 500 public companies. In addition to his extensive experience in the life science and pharmaceutical industry, he has held an adjunct faculty position and has experience in direct health care delivery. Sami has held various board membership positions in health care companies including in industry associations. Sami also serves on venture catalyst advisory boards.

Sami holds a BS in Microbiology and a BS in Molecular Genetics from UCLA, an MS in Biological Chemistry from Purdue University, a Pharm D from Creighton University, and an MBA from University of Michigan.

Chair, Corporate Development

Brian Zargham

Assistant Medical Director, Business Development

Barham K. Abu Dayyeh, MD, MPH

Associate Medical Director - FL, Business Development

Olayemi Sokumbi, MD

Olayemi (Yemi) Sokumbi, MD, serves as Associate Medical Director for the Department of Business Development at Mayo Clinic Florida, as well as an Associate Professor of Dermatology and Laboratory Medicine & Pathology in the Mayo Clinic Alix School of Medicine, Director of Clinical Practice in the Department of Dermatology, Chair for the Florida Mayo Medical School DEI Council, and Associate Program Director of the Mayo Clinic Florida Dermatology residency program.

Dr. Sokumbi is board-certified in dermatology and dermatopathology. She received her medical degree from Mayo Medical School in Rochester, Minnesota, where she also completed her preliminary year in internal medicine, her residency in dermatology and served as chief resident in her final year. Following residency, Dr. Sokumbi completed a fellowship in dermatopathology at the University of Texas Southwestern medical center in Dallas, Texas.

Her clinical and research interests include clinical-pathologic correlation of complex inflammatory skin disorders, quality improvement in dermatopathology, hidradenitis suppurativa, cutaneous lymphoproliferative disorders, and the development and assessment of deep neural network algorithms for diagnosis and image classification in dermatology and dermatopathology.

Associate Medical Director - AZ, Business Development

Steven J. Lester, MD

Steven Lester, MD, serves as Associate Medical Director for the Department of Business Development at Mayo Clinic Arizona as well as the Medical Director for the Mayo Clinic Complex Care Program and consultant in the Department of Cardiovascular Medicine. Dr. Lester is the founder and Chief Medical Officer of the Mayo Clinic and Arizona State University MedTech Accelerator program. He joined the staff of Mayo Clinic in 1999 and holds the academic rank of Professor of Medicine – Mayo Clinic College of Medicine and Science.

Dr. Lester earned his BS at the University of Western Ontario, his MD at the University of Toronto School of Medicine, and he completed his residency in internal medicine at St. Michael’s Hospital and The Toronto Hospital. He continued his training at the University of British Columbia, completing a cardiology fellowship, serving as chief cardiology fellow and went on to complete a 2-year cardiovascular imaging fellowship at the University of California San Francisco.

Mayo Clinic Ventures - Technology Licensing

Senior Director, Licensing
Timothy D. Argo, MBA

Technology Licensing Associate
Aslie Asberom

Senior Licensing Manager
Jonathon (Jon) H. Behringer

Technology Licensing Associate
Quentin G. Booker

Director, Licensing
Darren S. Carney, PhD

Technology Licensing Associate
Malcolm S. Cole, PhD

Technology Licensing Associate
Leah M. Corson

Technology Licensing Associate
Heaibert D. Diamond

Senior Licensing Manager
Seth T. Eisenman

Senior Director, Licensing
Barbara J. Keller

Technology Licensing Associate
Nolan M. Lawrence

Technology Licensing Associate
Lawrence L. Liu

Technology Licensing Associate
Kenneth M. Long

Senior Licensing Manager
Susan B. Mikell

Technology Licensing Associate
Eric J. Noonan

Technology Licensing Associate
Alexandra M. Norton

Senior Director, Licensing

Timothy D. Argo, MBA

As a Senior Director of Licensing, Tim is a member of the Mayo Clinic Ventures Executive Committee and contributes to the oversight and management of the division while staying active in management and licensing of technologies invented at Mayo Clinic. He is responsible for ensuring metrics and goals are met across the licensing team and leads through hiring and mentoring licensing staff. Tim is a Certified Licensing Professional. He received both his MBA with emphasis in Finance and BS in Microbiology from Kansas State University.

Technology Licensing Associate

Aslie Asberom

Aslie joined Business Development’s Mayo Clinic Ventures division in 2022. In her role as Technology Licensing Associate, Aslie supports the commercialization of Mayo Clinic intellectual property by identifying commercial collaborators and negotiating license agreements. Prior to joining Mayo Clinic, Aslie was a practicing attorney for an intellectual property clinic focused on providing IP protection (patents, trademarks, copyrights) for small business owners across Pennsylvania. She received her JD from Penn State Law.

Senior Licensing Manager

Jonathon (Jon) H. Behringer

Jon joined the Mayo Clinic Ventures division of Business Development in 2016. In his current role, Jon focuses on commercialization of diagnostic and orthopedic-based innovations, where he leads the biopharmaceutical and orthopedic licensing teams. Jon formerly worked in research and development in clinical DNA lab and developmental supervisory experience in food manufacturing. He receive his BS in biology with a biomedical science concentration and minor in chemistry from the University of Wisconsin-La Crosse and his Masters in Biotechnology from University of Wisconsin-Madison.

Technology Licensing Associate

Quentin G. Booker

Quentin is a Technology Licensing Associate in the Mayo Clinic Ventures division of Business Development where he is responsible for managing licensing and commercialization efforts for the biopharmaceutical, diagnostic, and research tools invention portfolios. Quentin received his BS in biology with a minor in chemistry from Xavier University of Louisiana and his JD from Southern University Law Center of Louisiana.

Specialist

Heather L. Brown

Director, Licensing

Darren S. Carney, PhD

Darren is a Director of Licensing in the Mayo Clinic Ventures division of the Department of Business Development where he leads the cardiology licensing team. Prior to his licensing role, he held positions of postdoctoral fellow and IP compliance specialist within the office. He received his BS in biochemistry and biology from Trinity University in San Antonio and PhD in biological chemistry from University of Texas Southwestern in Dallas.

Technology Licensing Associate

Malcolm S. Cole, PhD

Malcolm joined the Mayo Clinic Ventures division of Business Development in 2022 as a Technology Licensing Associate where he supports commercialization of Mayo Clinic intellectual property by identifying commercial collaborators and negotiating license agreements. Malcolm manages Mayo Clinic technologies related to biopharmaceuticals, medical devices and research tools. Prior to joining Business Development, Malcolm completed his PhD in Medicinal Chemistry at the University of Minnesota, where he served as an NIH T32 Trainee and a technology commercialization intern in the university’s technology commercialization office. Malcolm received his bachelor degrees in biochemistry and pharmaceutical sciences from Ohio State University.

Technology Licensing Associate

Leah M. Corson

Leah joined the Mayo Clinic Ventures division of the Department of Business Development in 2021 as a Technology Licensing Associate where she supports the licensing efforts of Mayo Clinic’s biopharma, cardiology and research tools portfolios. Prior to joining Business Development, Leah worked on patent prosecution, IP litigation and income tax matters through a variety of legal internships with law firms, in-house counsel and legal service providers. She also has research experience working in a neuroscience laboratory. Leah received her BA in chemistry from Smith College. She also holds a JD with a certificate in intellectual property law from the University of New Hampshire Franklin Pierce School of Law.

Technology Licensing Associate

Heaibert D. Diamond

Heaibert joined the Mayo Clinic Ventures division of Business Development in 2021 as a Technology Licensing Associate where he supports commercialization of Mayo Clinic intellectual property by identifying commercial collaborators and negotiating license agreements. Heaibert received his BA in English pre-law with a minor in innovation and entrepreneurship from University of Florida, and his MS in law with a specialization in IP and patent design, business law and regulatory strategy and analysis from Northwestern University Pritzker School of Law.

Licensing Manager II

Ryan K. Downing

Ryan joined the Mayo Clinic Ventures division of Business Development in 2021. In his current role, he focuses on licensing Mayo Clinic’s healthcare IT and biopharma-related technologies. Prior to joining Business Development, Ryan spent five years at the Oklahoma Medical Research Foundation where he licensed technologies to industry and executed an array of contracts to include sponsored research agreements, clinical trial agreements, and confidentiality agreements. Ryan received his BS in biology with a minor in chemistry from Western Illinois University.

Senior Licensing Manager

Seth T. Eisenman

Seth joined Business Development’s Mayo Clinic Ventures division in 2018. In his current role as Sr. Licensing Manager, he focuses on commercialization of diagnostic and orthopedic-based innovations, where he leverages relationships with industry, venture capitalists, and Mayo Clinic researchers and physicians to collaborate on development of next-generation solutions for unmet patient needs. He has been with Mayo Clinic since 2006 and has held roles within the Department of Laboratory Medicine and Pathology performing clinical testing and assay development in the Neuroimmunology Lab and has also worked in the Department of Physiology and Biomedical Engineering performing research on the pathophysiology of Interstitial cells of Cajal. Seth received his B.S. from St. John’s University in Collegeville, MN.

Specialist

Jodi L. Fritcher

Senior Director, Licensing

Barbara J. Keller

Barb joined Business Development in 2006 and in her role as Senior Director of Licensing, she is responsible for identifying, evaluating, and negotiating to commercialize Mayo Clinic technologies by working with Mayo Clinic staff, external companies, entrepreneurs and investors. She is a Mayo Clinic Ventures (MCV) Executive Committee member and oversees healthcare IT technologies, radiology and radiation oncology technologies. Barb is a member of Mayo Clinic’s Conflict of Interest Committee, the Mayo-Epic Joint Steering Committee, and the SAMD Committee. Additionally, Barb also serves on several external boards. Before joining Mayo Clinic in 2002, Barb worked as an IP analyst for IBM. Barb received her BS in Paralegal Studies from Winona State University, and her MA in Health and Human Service Administration and Management from Saint Mary’s University.

Technology Licensing Associate

Nolan M. Lawrence

Licensing Manager II

Kathryn E. Lenn

Katie is a Licensing Manager II in the Mayo Clinic Ventures division where she performs license negotiations for Mayo Clinic intellectual property. Since joining Business Development in 2019, she has supported the medical devices, healthcare IT, and research tools portfolios, and is currently managing files in the cardiology and orthopedics portfolios and leads the research tools team. Before joining Business Development, Katie held roles in clinical workflow, education coordination, and research management at Mayo Clinic. Katie earned her BS in Education from Winona State University in Winona, MN, and her MA in Health and Human Services from Saint Mary’s University of MN.

Technology Licensing Associate

Lawrence L. Liu

Technology Licensing Associate

Kenneth M. Long

Senior Licensing Manager

Susan B. Mikell

Susan joined Business Development in 2014 and currently serves as a Senior Licensing Manager, leading the diagnostic and device teams within Mayo Clinic Ventures. In this role, Susan is responsible for the management and execution of high value, complex licensing agreements. Prior to joining Business Development, Susan held the role of Program Coordinator in Cardiovascular Diseases Research at Mayo Clinic. Susan received her BA in English from the University of Texas in Austin.

Technology Licensing Associate

Eric J. Noonan

Technology Licensing Associate

Alexandra M. Norton

Mayo Clinic Ventures - Business & Technology Development

Technology Development Associate
Lindsey Andres-Beck, MS

Technology Development Manager
Jacqueline (Jacquie) L. Armstrong

Technology Development Associate - AZ campus
Kyle R. Brandy, MS

Technology Development Associate - AZ campus
Ryan M. Buchanan, MS

Sr. Technology Development Manager
Karla S. Frohmader Hilsaca, PhD

Technology Development Associate - FL campus
Alyssa P. Ghuman, MS

Technology Development Manager
Nir Goldenberg

Technology Development Associate
Kyle J. Korshavn, PhD

Sr. Director of Business Development
Kelly L. Krajnik, MBA

Technology Development Associate
Yu-Wei (Alex) Lin, MS, PhD

Technology Development Associate II
Stefan I. Madansingh, Ph.D.

Technology Development Associate
Spencer T. Mocarski

TECHNOLOGY DEVEVELOPMENT MANAGER
Kien T. Nguyen, Ph.D.

Director, Corporate Development Department of Business Development
Gloria R. Olivier, Ph.D.

Associate Technology Development Manager II
Shai Ran Sapir, Ph.D., M.B.A.

TECHNOLOGY DEVELOPMENT ASSOCIATE
Morgan Rea, Ph.D.

Technology Development Associate II
Faraz Samadi

Technology Development Associate

Lindsey Andres-Beck, MS

As a Technology Development Associate in Mayo Clinic Ventures, Lindsey supports the Department of Neurology where she works with external companies, entrepreneurs, and investors to facilitate the develop and commercialization of Mayo Clinic Neurology technologies. Prior to joining Business Development in 2022, Lindsey worked as a consultant providing scientific due diligence for angel investors. Lindsey received her MS in Molecular Pharmacology and Experimental Therapeutics from Mayo Clinic Graduate School of Biomedical Sciences where she utilized computer vision to generate 3D reconstructions and perform feature detection in serial image datasets from brain tissue imaged using serial block-face scanning electron microscopy (SBEM). She also served as a student representative and President of the Graduate Student Association.

Technology Development Manager

Jacqueline (Jacquie) L. Armstrong

Jacquie joined the Mayo Clinic Ventures division of Business Development in 2020 as a Technology Development Manager where she is currently responsible for facilitating the development and commercialization of Mayo Clinic technologies (focused on devices and healthcare IT) by working with Mayo Clinic staff and external companies, entrepreneurs and investors. Prior to joining Business Development, Jacquie worked in healthcare consulting and new product development. Jacquie received her BS in engineering from McMaster University and her MBA from Babson College.

Technology Development Associate - AZ campus

Kyle R. Brandy, MS

Kyle joined the Mayo Clinic Ventures division of the Department of Business Development in 2021 and in his role of Technology Development Associate is responsible for facilitating the development and commercialization of Mayo Clinic technologies by working with Mayo Clinic staff in Arizona and external companies, entrepreneurs and investors. Prior to joining Business Development, Kyle worked in the Genomics lab within the Department of Lab Medicine and Pathology at Mayo Clinic. Kyle received his BS in Biochemistry and MS in Clinical Laboratory Science from the University of Minnesota.

Technology Development Associate - AZ campus

Ryan M. Buchanan, MS

Ryan joined the Mayo Clinic Ventures division of the Department of Business Development in 2022 as a Technology Development Associate where he is responsible for facilitating the development and commercialization of Mayo Clinic technologies by working with Mayo Clinic staff and external companies, entrepreneurs, and investors. Prior to joining Business Development, Ryan worked as a Director of Molecular Operations for a precision medicine company that delivered tailored treatment plans for an individual’s cancer diagnosis. His various roles included oversite of the sequencing laboratory, method development support, laboratory design and regulatory compliance. Ryan received his MS in Pharmacy from the University of Florida and an MBA from Northern Arizona University.

Sr. Technology Development Manager

Karla S. Frohmader Hilsaca, PhD

Karla joined Business Development’s Mayo Clinic Ventures division in 2018 and as a Senior Technology Development Manager, she supports technology development and business development of gene and cell therapies advancing through the Center for Regenerative Biotherapeutics and across the Mayo Clinic enterprise. Prior to joining Business Development, Karla held a role as Program Research Coordinator for the Women’s Health Clinic at Mayo Clinic. Karla received her BS and PhD in Neuroscience from the University of Western Ontario in Canada followed by postdoctoral training at the University of Michigan in Ann Arbor.

Technology Development Associate - FL campus

Alyssa P. Ghuman, MS

Alyssa joined Business Development’s Mayo Clinic Ventures division in 2019 and currently serves as a Technology Development Associate where she evaluates IP potential, determines commercial viability, and supports early technology development for medical Devices and Digital Health technologies coming out of Mayo Clinic Florida. She is based on the Mayo Clinic Jacksonville, Florida campus. Prior to her role as Technology Development Associate, Alyssa was a Patent Liaison within Mayo Clinic Ventures supporting devices, orthopedic, and cardiology patent portfolios from across the enterprise. Alyssa received both her BS and MS in Biomedical Engineering from the University of Georgia. She is a registered Patent Agent with the USPTO.

Technology Development Manager

Nir Goldenberg

Nir joined Business Development’s Mayo Clinic Ventures division in 2022 as a Technology Development Manager where he is responsible for facilitating the development and commercialization of technologies from Mayo Clinic’s Department of Surgery by working with internal stakeholders and external companies, entrepreneurs and investors. Prior to joining Business Development, Nir was CEO of Trendlines Innovation Labs, a business unit of The Trendlines Group focused on both in-house and collaborative invention and investment opportunities in the life science space. Prior to his appointment as CEO, Nir served as Trendlines Innovation Labs VP Business Development. Before joining Trendlines, Nir was Director of Commercial Development, Europe at INSIGHTEC Ltd., a global MR-guided focused ultrasound surgery company. Nir holds a BSc in engineering from La Sapienza University of Rome.

Technology Development Associate

Kyle J. Korshavn, PhD

As a Technology Development Associate in Mayo Clinic Ventures, Kyle prioritizes the identification, development, and commercialization of biotherapeutic technologies across the Mayo Clinic enterprise. His particular focus is on molecular therapeutics, including small molecules, peptides and antibodies. Kyle is also a registered patent agent with the U.S. Patent and Trademark Office. Prior to joining Mayo Clinic in 2020, he was an American Cancer Society postdoctoral fellow at the Dana-Farber Cancer Institute and has published 20 peer reviewed research articles. Kyle received his PhD in Chemistry from the University of Michigan – Ann Arbor, and his BS in Biochemistry from Valparaiso University.

Sr. Director of Business Development

Kelly L. Krajnik, MBA

Kelly joined Business Development in 2006 and is responsible for facilitating the development and commercialization of Mayo Clinic technologies by working with Mayo Clinic staff and external companies, entrepreneurs and investors. She is a member of the Mayo Clinic Ventures Executive Committee, leading the technology and business development function, and administering MCV’s seed/angel fund program and chairing its investment committee. Prior to joining Business Development, Kelly worked as a Senior Research Technologist developing and conducting microarray expression protocols in support of Mayo Clinic research programs and served on a Mayo Clinic Institutional Review Board. Kelly received her BS in Microbiology from University of Wisconsin – La Crosse, and her MBA from the University of St. Thomas. She is also a registered Patent Agent with the USPTO.

Technology Development Associate

Yu-Wei (Alex) Lin, MS, PhD

Alex joined Mayo Clinic Ventures in 2022 as a Technology Development Associate where he supports the development and commercialization of digital health and healthcare IT technologies. Prior to joining Mayo Clinic, Alex was a postdoctoral research fellow at Lawrence Berkeley National Laboratory working on biomaterials synthesis and high-throughput materials discovery using automated transmission electron microscopy. For his research work, Alex was awarded the Apkarian Memorial Scholarship by the Microscopy Society of America in 2022. Alex received his BS and MS degrees in Materials Science and Engineering from Northwestern University in 2016 and his PhD in Materials Science and Engineering also from Northwestern University in 2020.

Technology Development Associate II

Stefan I. Madansingh, Ph.D.

Technology Development Associate

Spencer T. Mocarski

Spencer joined Mayo Clinic Ventures in 2022 as a Technology Development Associate where he is responsible for supporting the development and commercialization of new technologies and innovations produced by clinicians and research innovators within Mayo Clinic’s Center for Individualized Medicine. Prior to joining Mayo Clinic Ventures, he worked as a Product Manager at a Nashville-based start-up, Greenlight Medical, where he helped develop and pilot new software products to help health system formularies evaluate drug procurement decisions. Spencer received his BS in Biomedical Biology from Saint Norbert College in 2018 and his PharmD from Lipscomb University in 2022.

TECHNOLOGY DEVEVELOPMENT MANAGER

Kien T. Nguyen, Ph.D.

Director, Corporate Development Department of Business Development

Gloria R. Olivier, Ph.D.

Associate Technology Development Manager II

Shai Ran Sapir, Ph.D., M.B.A.

TECHNOLOGY DEVELOPMENT ASSOCIATE

Morgan Rea, Ph.D.

Technology Development Associate II

Faraz Samadi

Faraz joined Mayo Clinic Ventures in 2023 as a Technology Development Associate II, serving as a resource for Mayo Clinic’s Radiology Department to identify, evaluate, and protect new technologies and innovations arising from research and clinical activities. Faraz acts as a liaison to innovators as well as to external entrepreneurs and investors in order to protect and advance Mayo Clinic technologies. Prior to joining Mayo Clinic Ventures, Faraz was a staff Diagnostic Radiologist at Iowa City’s VA and affiliated University of Iowa Health Care Systems, and a part-year Interventional Radiology Fellow at Harvard University (Brigham and Women’s Hospital), who completed residency at the University of Pittsburgh Medical Center, and received his MD and BA from the University of Pennsylvania, where he was a Benjamin Franklin Honors Program Scholar, and later a Rotary Foundation Scholar.

Technology Development Associate II - FL campus

Nichole S. Solana, MS

Mayo Clinic Ventures - Patent Prosecution

Senior Director - Business Development
Julie A. Henry, MBA

Senior Patent Liaison
Eva C. Kathmann, Ph.D.

Patent Liaison
Chelsea M. Lassiter, Ph.D.

Patent Liaison

Sebastien Founta, Ph.D.

Patent Liaison

Lena Haidous

Patent Liaison

Mack N. Haynes, JR

Senior Director - Business Development

Julie A. Henry, MBA

Julie is a Senior Director in the Department of Business Development where her responsibilities involve collaborating with internal and external customers as a resource for guidance, oversight, coordination and execution of unique and complex legal and contract agreement work related to agreements/opportunities emanating from Mayo Clinic Executive leadership and Mayo Clinic’s respective governing boards. Additionally, she is involved with the patent strategy of Mayo Clinic inventions and provides primary supervision for the patent team. Julie has been with Mayo Clinic for more than thirty years. She has experience in all facets of the commercialization process including drafting, negotiating and management of agreements. Julie received her BA in Biomedical Science from St. Cloud State University in St. Cloud, Minnesota and her MBA from University of St. Thomas in Minneapolis, Minnesota.

Senior Patent Liaison

Eva C. Kathmann, Ph.D.

Patent Liaison

Chelsea M. Lassiter, Ph.D.

Patent Liaison

Anna A. Song

Corporate Development

Director - Business Partnerships
Patrick (Pat) P. Bezenek, MBA, FACHE

Director - Business Partnership
Dustin E. Bilton, M.B.A., FACHE

Director, Corporate Development Operations
Michael (Mike) J. Boguszewski

Senior Corporate Development Associate
Elizabeth (Beth) A. Determan, MBA

Senior Corporate Dev Associate
Mary S. Fan

Senior Corporate Dev Associate
Andrew (Andy) T. Farmer, M.B.A.

Director, Corporate Development
Joshua E. Francis, M.B.A.

Senior Director, Corporate Development
Michael J. Harris

Corporate Development Manager
Jennifer (Jen) L. LaNasa, M.B.A.

Senior Manager - Corporate Development
Muddassir Laique, CFA

Senior Manager - Corporate Development
George (Chris) C. Lawrence

Corporate Development Manager
John N. Maragos, MBA

DIRECTOR CORPORATE DEVELOPMENT
Steve P. Nelson, J.D.

Director, Corporate Development
Melissa M. Noel, M.S., M.B.A.

Director, Corporate Development
Craig W. Pike, MBA

Senior Manager - Corporate Development
Anantha V. Santhanam, PhD, MBA

Corporate Development Manager
John (Jack) P. Schneeman, MBA

Corporate Dev Associate
Lauren A. Seidenschmidt, MHA

Director, Corporate Development
Prathib Skandakumaran, MBA

Senior Corporate Dev Associate
Paul (Matthew) M. Steinmetz, MBA

Director - Business Partnerships

Patrick (Pat) P. Bezenek, MBA, FACHE

In his role as Director – Business Partnerships within the Corporate Development division of Business Development, Pat is responsible for identifying and developing non-traditional opportunities to expand both the clinical and geographic reach for Mayo Collaborative Services. Prior to this role, Pat served as the Regional Director for Mayo Clinical Laboratories Sales and Service. Prior to joining Mayo Clinic, Pat has held leadership positions in sales, marketing, and clinical operations. Pat is an ASCP-certified clinical laboratory scientist who holds an MBA from National American University and a Bachelor of Business Management from University of Mary. Pat earned his Fellowship credential from the American College of Healthcare Executives.

Director - Business Partnership

Dustin E. Bilton, M.B.A., FACHE

Director, Corporate Development Operations

Michael (Mike) J. Boguszewski

Senior Corporate Development Associate

Elizabeth (Beth) A. Determan, MBA

Beth joined the Corporate Development division of Business Development in 2022. In her current role as Corporate Development Senior Associate, Beth assists in the evaluation, analysis and development of new business opportunities for Mayo Clinic. Prior to joining Business Development, she served as a Financial Analyst at Mayo Clinic in Research. She previously worked at IBM as a Financial Analyst in Federal Contracts. Beth received her BS from Winona State University with an emphasis in accounting, business administration and human resource management and her MBA from Upper Iowa University.

Senior Corporate Dev Associate

Mary S. Fan

Senior Corporate Dev Associate

Andrew (Andy) T. Farmer, M.B.A.

Director, Corporate Development

Joshua E. Francis, M.B.A.

Senior Director, Corporate Development

Michael J. Harris

Corporate Development Manager

Jennifer (Jen) L. LaNasa, M.B.A.

Senior Manager - Corporate Development

Muddassir Laique, CFA

Senior Manager - Corporate Development

George (Chris) C. Lawrence

Corporate Development Manager

John N. Maragos, MBA

As a Manager in Corporate Development focused on strategic transactions, John provides evaluation, analysis and development of new business opportunities for Mayo Clinic. John joined Mayo Clinic in 2015, supporting the Biorepositories Program within the Center for Individualized Medicine. He served as program manager of the All of Us Research Program, partnering administratively with two principal investigators while overseeing nearly $400 million in research grant allocations. Prior to Mayo Clinic, John worked in both the private and non-profit sectors for more than fifteen years. He served in roles within finance, management, and business consulting. John earned his MBA and a Master of Project Management from St. Mary’s University of Minnesota. He holds bachelor degrees in Business & Administration and Acoustical Engineering, graduating from Berklee College of Music in Boston, and he is a certified Project Management Professional (PMP).

DIRECTOR CORPORATE DEVELOPMENT

Steve P. Nelson, J.D.

Director, Corporate Development

Melissa M. Noel, M.S., M.B.A.

Director, Corporate Development

Craig W. Pike, MBA

Craig is currently a Director in Corporate Development, leading institution-wide strategic partnership and M&A initiatives. He began his career at Mayo Clinic in 2007, serving in an array of finance roles before joining Mayo Clinic’s Strategic Planning group. Craig then joined Business Development in 2015, transitioned to Mayo Clinic International upon its’ inception in 2020 where he helped establish finance and data analytics functions for the new business. Craig rejoined Corporate Development in late 2022. Prior to his tenure at Mayo Clinic, Craig worked in a variety of finance roles at several regional and national organizations. Craig holds BA degrees in Accounting and Finance and received his MBA from Augsburg University.

Senior Manager - Corporate Development

Anantha V. Santhanam, PhD, MBA

In his role as Senior Manager in Corporate Development, Anantha develops new business opportunities for Mayo Clinic to meet the organization’s strategic priorities and goals, collaborating with leadership teams across the enterprise to structure partnerships and create new ventures and spin-offs with emphasis in the radiology and radiation oncology space. Anantha received his PhD in Pharmacology from Birla Institute of Technology & Science in India and his MBA from Carlson School of Management – University of Minnesota.

Corporate Development Manager

John (Jack) P. Schneeman, MBA

As a Manager in Corporate Development since 2021, Jack supports the evaluation, analysis and development of new business opportunities including partnerships, strategic collaborations, new company spin-offs, mergers and acquisitions. He previously served in roles of digital health co-founder, private equity investor, investment banker, strategic consultant, and U.S. Army officer. Jack received his BS in Finance from Santa Clara University and his MBA from the University of Minnesota.

Corporate Dev Associate

Lauren A. Seidenschmidt, MHA

Lauren joined the Corporate Development team as an Associate in March 2023. She has more than ten years of experience working in health care primarily coming from her tenure at the Medical University of South Carolina which included the roles of Palliative Care Program Manager and Senior Internal Consultant. A career highlight for Lauren was receiving $1.26 million in funding to start the first, non-federally funded Palliative Telemedicine service in South Carolina.

In May 2020, Lauren received her MHA degree from the Medical University of South Carolina and obtained her Project Management Professional (PMP) certification in 2022.

Director, Corporate Development

Prathib Skandakumaran, MBA

Prathib is a Director in Corporate Development where he leads deal flow, investments and partnerships for Mayo Clinic Platform. Since joining Business Development in 2019, Prathib has led transactions with Medically Home, Lucem Health, TripleBlind, Diagnostic Robotics and Becton Dickinson. Prathib previously worked in health tech product management at Surescripts and in management consulting at Booz Allen. He holds a BS in Bioengineering from University of California, Berkeley and an MBA from Carnegie Mellon University – Tepper School of Business.